Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases.

Uppal A, Smieliauskas F, Sharma MR, Maron SB, Polite BN, Posner MC, Turaga K.

Cancer. 2020 Jan 15;126(2):281-292. doi: 10.1002/cncr.32529. Epub 2019 Oct 22.

PMID:
31639217
2.

Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using UGT1A1 Genotype-Guided Dosing.

Joshi SS, Catenacci DVT, Karrison TG, Peterson JD, Zalupski MM, Sehdev A, Wade J, Sadiq A, Picozzi VJ, Amico A, Marsh R, Kozloff MF, Polite BN, Kindler HL, Sharma MR.

Clin Cancer Res. 2020 Jan 1;26(1):18-24. doi: 10.1158/1078-0432.CCR-19-1483. Epub 2019 Sep 26.

PMID:
31558477
3.

Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405.

Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K, Ng K, Van Blarigan E, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA.

J Clin Oncol. 2019 Oct 10;37(29):2620-2631. doi: 10.1200/JCO.19.01019. Epub 2019 Aug 13.

4.

Opaque Results of Federal Price Transparency Rules and State-Based Alternatives.

Kircher SM, Royce TJ, Upadhyay D, Polite BN.

J Oncol Pract. 2019 Sep;15(9):463-464. doi: 10.1200/JOP.19.00354. Epub 2019 Aug 12. No abstract available.

PMID:
31403893
5.

Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.

Polite BN, Gluck AR, Brawley OW.

JAMA. 2019 May 7;321(17):1663-1664. doi: 10.1001/jama.2019.4266. No abstract available.

PMID:
30958509
6.

State of Cancer Care in America: Reflections on an Inaugural Year.

Polite BN, Seid JE, Freeman M, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Schilsky RL.

J Oncol Pract. 2019 Apr;15(4):163-165. doi: 10.1200/JOP.18.00746. Epub 2019 Mar 11. No abstract available.

PMID:
30856037
7.

Investigation of a multimedia, computer-based approach to improve knowledge, attitudes, self-efficacy, and receptivity to cancer clinical trials among newly diagnosed patients with diverse health literacy skills.

Polite BN, Cipriano-Steffens TM, Liao C, Miller EL, Arndt NL, Hahn EA.

Cancer. 2019 Jun 15;125(12):2066-2075. doi: 10.1002/cncr.31991. Epub 2019 Feb 27.

PMID:
30811591
8.

A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.

Sharma MR, Joshi SS, Karrison TG, Allen K, Suh G, Marsh R, Kozloff MF, Polite BN, Catenacci DVT, Kindler HL.

Cancer. 2019 May 15;125(10):1629-1636. doi: 10.1002/cncr.31938. Epub 2019 Jan 15.

PMID:
30645764
9.

Cost-effectiveness of Maintenance Capecitabine and Bevacizumab for Metastatic Colorectal Cancer.

Sherman SK, Lange JJ, Dahdaleh FS, Rajeev R, Gamblin TC, Polite BN, Turaga KK.

JAMA Oncol. 2019 Feb 1;5(2):236-242. doi: 10.1001/jamaoncol.2018.5070.

10.

Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial.

Dahdaleh FS, Sherman SK, Poli EC, Vigneswaran J, Polite BN, Sharma MR, Catenacci DV, Maron SB, Turaga KK.

Surgery. 2018 Dec;164(6):1223-1229. doi: 10.1016/j.surg.2018.06.044. Epub 2018 Oct 5.

PMID:
30297240
11.

Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.

Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J; Timing of Rectal Cancer Response to Chemoradiation Consortium.

Dis Colon Rectum. 2018 Oct;61(10):1146-1155. doi: 10.1097/DCR.0000000000001207.

12.

Engaging Patients in Value-Based Cancer Care: A Missed Opportunity.

Zafar SY, Polite BN, McClellan M.

JAMA Oncol. 2018 Nov 1;4(11):1479-1480. doi: 10.1001/jamaoncol.2018.2826. No abstract available.

PMID:
30073281
13.

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Sehdev A, Karrison T, Zha Y, Janisch L, Turcich M, Cohen EEW, Maitland M, Polite BN, Gajewski TF, Salgia R, Pinto N, Bissonnette MB, Fleming GF, Ratain MJ, Sharma MR.

Cancer Chemother Pharmacol. 2018 Aug;82(2):309-317. doi: 10.1007/s00280-018-3619-3. Epub 2018 Jun 9.

14.

A New Look at the State of Cancer Care in America.

Polite BN, Seid JE, Levit LA, Kirkwood MK, Schenkel C, Bruinooge SS, Grubbs SS, Kamin DY, Schilsky RL.

J Oncol Pract. 2018 Jul;14(7):397-399. doi: 10.1200/JOP.18.00150. Epub 2018 Jun 15. No abstract available.

PMID:
29906212
15.

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey.

Kirkwood MK, Hanley A, Bruinooge SS, Garrett-Mayer E, Levit LA, Schenkel C, Seid JE, Polite BN, Schilsky RL.

J Oncol Pract. 2018 Jul;14(7):e412-e420. doi: 10.1200/JOP.18.00149. Epub 2018 Jun 15.

PMID:
29906211
16.

Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.

Wellmann R, Borden BA, Danahey K, Nanda R, Polite BN, Stadler WM, Ratain MJ, O'Donnell PH.

Cancer. 2018 Jul 15;124(14):3052-3065. doi: 10.1002/cncr.31382. Epub 2018 May 9.

17.

A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning.

Bestvina CM, Wroblewski KE, Daly B, Beach B, Chow S, Hantel A, Malec M, Huber MT, Polite BN.

J Palliat Med. 2018 Jun;21(6):846-849. doi: 10.1089/jpm.2017.0408. Epub 2018 Mar 13.

PMID:
29649399
18.

Impact on Oncology Practices of Including Drug Costs in Bundled Payments.

Ward JC, Levit LA, Page RD, Hennessy JE, Cox JV, Kamin DY, Bruinooge SS, Shih YT, Polite BN.

J Oncol Pract. 2018 May;14(5):e259-e268. doi: 10.1200/JOP.17.00036. Epub 2018 Apr 12.

PMID:
29648923
19.

Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.

Polite BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, Cheng Y, Brewer KC, Rauscher GH, Fitchett GA.

Cancer. 2018 Jun 15;124(12):2578-2587. doi: 10.1002/cncr.31351. Epub 2018 Mar 26.

20.

The Road From Theory to Reality: Illuminating the Complexity of Prospective Cancer Bundles.

Polite BN.

J Oncol Pract. 2018 Feb;14(2):59-61. doi: 10.1200/JOP.2017.029090. Epub 2018 Jan 18. No abstract available.

PMID:
29346022
21.

Examining racial disparities in colon cancer clinical delay in the Colon Cancer Patterns of Care in Chicago study.

Jones LA, Ferrans CE, Polite BN, Brewer KC, Maker AV, Pauls HA, Rauscher GH.

Ann Epidemiol. 2017 Nov;27(11):731-738.e1. doi: 10.1016/j.annepidem.2017.10.006. Epub 2017 Oct 13.

22.

Blase Polite on How Disparities Research Must Move Into an Era of Action.

Polite BN.

Oncology (Williston Park). 2017 Oct 15;31(10):709-10, 717. No abstract available.

23.

Charting the Future of Cancer Health Disparities Research: A Position Statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

Cancer Res. 2017 Sep 1;77(17):4548-4555. doi: 10.1158/0008-5472.CAN-17-0623. Epub 2017 Jul 24. No abstract available.

24.

Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

CA Cancer J Clin. 2017 Sep;67(5):353-361. doi: 10.3322/caac.21404. Epub 2017 Jul 24. No abstract available.

25.

Charting the Future of Cancer Health Disparities Research: A Position Statement From the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute.

Polite BN, Adams-Campbell LL, Brawley OW, Bickell N, Carethers JM, Flowers CR, Foti M, Gomez SL, Griggs JJ, Lathan CS, Li CI, Lichtenfeld JL, McCaskill-Stevens W, Paskett ED.

J Clin Oncol. 2017 Sep 10;35(26):3075-3082. doi: 10.1200/JCO.2017.73.6546. Epub 2017 Jul 24. No abstract available.

PMID:
28737975
26.

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Fruth B, Meyerhardt JA, Schrag D, Greene C, O'Neil BH, Atkins JN, Berry S, Polite BN, O'Reilly EM, Goldberg RM, Hochster HS, Schilsky RL, Bertagnolli MM, El-Khoueiry AB, Watson P, Benson AB 3rd, Mulkerin DL, Mayer RJ, Blanke C.

JAMA. 2017 Jun 20;317(23):2392-2401. doi: 10.1001/jama.2017.7105.

27.

Under-representation of peritoneal metastases in published clinical trials of metastatic colorectal cancer.

Tseng J, Bryan DS, Poli E, Sharma M, Polite BN, Turaga KK.

Lancet Oncol. 2017 Jun;18(6):711-712. doi: 10.1016/S1470-2045(17)30336-4. No abstract available.

PMID:
28593843
28.

Implementation of Advance Care Planning in Oncology: A Review of the Literature.

Bestvina CM, Polite BN.

J Oncol Pract. 2017 Oct;13(10):657-662. doi: 10.1200/JOP.2017.021246. Epub 2017 Jun 6. Review.

PMID:
28586259
29.

Dynamic Equilibrium.

Nabhan A, Polite BN.

J Oncol Pract. 2017 Jun;13(6):345-347. doi: 10.1200/JOP.2016.020305. Epub 2017 Apr 17. No abstract available.

PMID:
28414556
30.

Exceptional Chemotherapy Response in Metastatic Colorectal Cancer Associated With Hyper-Indel-Hypermutated Cancer Genome and Comutation of POLD1 and MLH1.

Sharma MR, Auman JT, Patel NM, Grilley-Olson JE, Zhao X, Moschos SJ, Parker JS, Yin X, Hayward MC, Polite BN, Marangon E, Posocco B, Toffoli G, Hayes DN, Innocenti F.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.16.00015. Epub 2017 Apr 27.

31.

Reply to P.B. Bach.

Polite BN, Kamin DY, Grubbs SS.

J Clin Oncol. 2016 Dec 20;34(36):4448-4449. Epub 2016 Oct 31. No abstract available.

PMID:
27998228
32.

No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations.

Daly B, Hantel A, Wroblewski K, Balachandran JS, Chow S, DeBoer R, Fleming GF, Hahn OM, Kline J, Liu H, Patel BK, Verma A, Witt LJ, Fukui M, Kumar A, Howell MD, Polite BN.

J Oncol Pract. 2016 Oct;12(10):e901-e911.

33.

Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer.

Toffoli G, Sharma MR, Marangon E, Posocco B, Gray E, Mai Q, Buonadonna A, Polite BN, Miolo G, Tabaro G, Innocenti F.

Clin Cancer Res. 2017 Feb 15;23(4):918-924. doi: 10.1158/1078-0432.CCR-16-1012. Epub 2016 Aug 9.

34.

An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.

Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert S.

J Racial Ethn Health Disparities. 2017 Apr;4(2):140-148. doi: 10.1007/s40615-016-0211-6. Epub 2016 Mar 16.

PMID:
26983622
35.

Oncology Pathways-Preventing a Good Idea From Going Bad.

Polite BN, Page RD, Nabhan C.

JAMA Oncol. 2016 Mar;2(3):297-8. doi: 10.1001/jamaoncol.2015.5778. No abstract available.

PMID:
26847876
36.

Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma.

Raoul JL, Park JW, Kang YK, Finn RS, Kim JS, Yeo W, Polite BN, Chao Y, Walters I, Baudelet C, Lencioni R.

Liver Cancer. 2014 Oct;3(3-4):439-50. doi: 10.1159/000343872. Review.

37.

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide.

O'Donnell PH, Karovic S, Karrison TG, Janisch L, Levine MR, Harris PJ, Polite BN, Cohen EE, Fleming GF, Ratain MJ, Maitland ML.

Clin Cancer Res. 2015 Nov 15;21(22):5092-9. doi: 10.1158/1078-0432.CCR-15-0427. Epub 2015 Jul 21.

38.

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Garcia-Aguilar J, Chow OS, Smith DD, Marcet JE, Cataldo PA, Varma MG, Kumar AS, Oommen S, Coutsoftides T, Hunt SR, Stamos MJ, Ternent CA, Herzig DO, Fichera A, Polite BN, Dietz DW, Patil S, Avila K; Timing of Rectal Cancer Response to Chemoradiation Consortium.

Lancet Oncol. 2015 Aug;16(8):957-66. doi: 10.1016/S1470-2045(15)00004-2. Epub 2015 Jul 14.

39.

Medicare innovation center oncology care model: a toe in the water when a plunge is needed.

Polite BN, Miller HD.

J Oncol Pract. 2015 Mar;11(2):117-9. doi: 10.1200/JOP.2014.002899. Epub 2015 Feb 17. No abstract available.

PMID:
25690595
40.

Eliminating racial disparities in colorectal cancer in the real world: it took a village.

Grubbs SS, Polite BN, Carney J Jr, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED.

Del Med J. 2014 Oct;86(10):301-5. No abstract available.

PMID:
25647858
41.

States as the laboratory for democracy: is anybody paying attention, and does anybody care?

Polite BN.

J Clin Oncol. 2015 Mar 10;33(8):815-6. doi: 10.1200/JCO.2014.59.4135. Epub 2015 Jan 20. No abstract available.

PMID:
25605832
42.

Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.

Sehdev A, Shih YC, Vekhter B, Bissonnette MB, Olopade OI, Polite BN.

Cancer. 2015 Apr 1;121(7):1071-8. doi: 10.1002/cncr.29165. Epub 2014 Nov 25.

43.

American Society of Clinical Oncology policy statement on medicaid reform.

Polite BN, Griggs JJ, Moy B, Lathan C, duPont NC, Villani G, Wong SL, Halpern MT.

J Clin Oncol. 2014 Dec 20;32(36):4162-7. doi: 10.1200/JCO.2014.56.3452. Epub 2014 Nov 17. No abstract available.

44.

Payment for oncolytics in the United States: a history of buy and bill and proposals for reform.

Polite BN, Ward JC, Cox JV, Morton RF, Hennessy J, Page RD, Conti RM.

J Oncol Pract. 2014 Nov;10(6):357-62. doi: 10.1200/JOP.2014.001958. No abstract available.

45.

Achieving a deeper understanding of the implemented provisions of the Affordable Care Act.

Zhang SQ, Polite BN.

Am Soc Clin Oncol Educ Book. 2014:e472-7. doi: 10.14694/EdBook_AM.2014.34.e472. Review.

46.

Factors associated with compliance to adjuvant hormone therapy in Black and White women with breast cancer.

Bhatta SS, Hou N, Moton ZN, Polite BN, Fleming GF, Olopade OI, Huo D, Hong S.

Springerplus. 2013 Jul 30;2:356. doi: 10.1186/2193-1801-2-356. eCollection 2013.

47.

Qualitative analysis of practicing oncologists' attitudes and experiences regarding collection of patient-reported outcomes.

Jagsi R, Chiang A, Polite BN, Medeiros BC, McNiff K, Abernethy AP, Zon R, Loehrer PJ Sr.

J Oncol Pract. 2013 Nov;9(6):e290-7. doi: 10.1200/JOP.2012.000823. Epub 2013 Aug 6.

PMID:
23943890
48.

Achieving health equity in colorectal cancer: a call to action.

Cipriano TM, Polite BN.

Am Soc Clin Oncol Educ Book. 2013:169-73. doi: 10.1200/EdBook_AM.2013.33.169.

49.

Eliminating racial disparities in colorectal cancer in the real world: it took a village.

Grubbs SS, Polite BN, Carney J Jr, Bowser W, Rogers J, Katurakes N, Hess P, Paskett ED.

J Clin Oncol. 2013 Jun 1;31(16):1928-30. doi: 10.1200/JCO.2012.47.8412. Epub 2013 Apr 15. No abstract available.

50.

A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma.

Geynisman DM, Zha Y, Kunnavakkam R, Aklilu M, Catenacci DV, Polite BN, Rosenbaum C, Namakydoust A, Karrison T, Gajewski TF, Kindler HL.

J Immunother Cancer. 2013 Jun 27;1:8. doi: 10.1186/2051-1426-1-8. eCollection 2013.

Supplemental Content

Loading ...
Support Center